Editor

Amiji, Mansoor M.

Milane, Lara Scheherazade

Place of Publication

Cambridge, MA

Publisher

Elsevier Science and Technology

Academic Press

Publication Date

2021

Series

Proquest Ebook Central

Subjects

Immunotherapy - methods

Neoplasms - immunology

Neoplasms - therapy

ISBN

9780128233979

9780128236376

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Alternate Title

Cancer immunotherapy

Editor

Butterfield, Lisa H.

Kaufman, Howard L.

Marincola, Francesco M.

Edition

2nd ed.

Place of Publication

New York, NY

Publisher

Demos Medical Publishing

Publication Date

2021

Series

Proquest Ebook Central

Subjects

Neoplasms - therapy

Immunotherapy - methods

Neoplasms - immunology

ISBN

9780826137425

9780826137432

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted

Editor

Rezaei, Nima

Edition

2nd ed.

Place of Publication

Cham, Switzerland

Publication Date

2020

Series

Proquest Ebook Central

Subjects

Neoplasms - therapy

Immunotherapy - methods

Immunomodulation

Organ Specificity

ISBN

9783030579487

9783030579494

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Naing, Aung

Hajjar, Joud

Edition

3rd ed,

Place of Publication

Cham, Switzerland

Publisher

Springer Nature Switzerland AG

Publication Date

2020

Series

Proquest Ebook Central

Advances in experimental medicine and biology

Subjects

Immunotherapy

ISBN

9783030410070

9783030410087

ISSN

0065-2598

2214-8019

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Author

Olle, David A.

Edition

2nd ed.

Place of Publication

Dulles, VA

Publisher

Mercury Learning and Information

Publication Date

2022

Physical Description

xiii, 161 pages : colour illustrations ; 23 cm

Series

Proquest Ebook Central

Subjects

Neoplasms - therapy

Immunotherapy

Precision Medicine

Popular Work

ISBN

9781683927549

9781683927532

Language

English

Material Type

Ebook

Book

Audience

Patient or Public

Location

Abbotsford Cancer Info Ctr

Vancouver Library

Victoria Cancer Info Ctr

Kelowna Cancer Info Ctr

Internet

Call Number

QZ266 O49t 2022

Website Notes

Patients and the public of BC and the Yukon can access this title by emailing library@bccancer.bc.ca or calling 1.888.675.8001 x 7000 (toll-free) to obtain a username and password.

Copies

Editor

Bajek, Anna

Tylkowski, Bartosz

Edition

1st ed.

Place of Publication

Berlin, Germany

Publisher

Walter de Gruyter

Publication Date

c2021

Series

Proquest Ebook Central

Subjects

Neoplasms - diagnosis

Neoplasms - therapy

Neoplasms - immunology

Nanotechnology

Computational Biology

Abstract

"Modern cancer research is a high-tech undertaking, overlapping with many fields in the physical sciences. These include nanotechnology, engineering, immunology, and bioinformatics. This book focuses on the science and technology underlying the diagnosis and treatement of cancer. The authors offer insights into technologies including radiotherapy, modelling, and drug encapsulation." --publisher

ISBN

9783110662306

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Alternate Title

Fast facts : immunooncology

Author

Clarke, Stephon

Li, Bob T.

Edition

2nd ed.

Place of Publication

Abingdon, UK

Publisher

S. Karger Publishers Ltd.

Publication Date

2021

Physical Description

126 p. : ill ; 21 cm.

Series

Fast facts (UK)

R2 Library

Subjects

Immunotherapy

Neoplasms - therapy

Neoplasms - immunology

ISBN

3318068217

9783318068214

9783318068221

Language

English

Material Type

Book

Ebook

Audience

Professional

Location

Abbotsford Library

Kelowna Library

Call Number

QZ267 C597 2021

Website Notes

This R2 title is licensed for unlimited BC Cancer staff users. Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Copies

Author

Cavalcanti, Iago Dillion Lima

Soares, José Cleberson Santos

Place of Publication

Cham, Switzerland

Publisher

Springer Nature Switzerland AG

Publication Date

2021

Series

Proquest Ebook Central

Subjects

Neoplasms - therapy

Neoplasms - epidemiology

Neoplasms - immunology

Abstract

Summary:

ISBN

9783030683337

9783030683344

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer network computer. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Ghobadi, Armin

DiPersio, John F.

Edition

1st ed.

Place of Publication

Cham, Switzerland

Publisher

Humana Press

Publication Date

c2022

Series

Proquest Ebook Central

Subjects

Immunotherapy, Adoptive

Lymphoma

Leukemia

Lymphocytes, Tumor-Infiltrating

Abstract

"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia (ALL). These advances have dramatically improved the management of patients with relapsed refractory lymphoma, myeloma and leukemia. Gene and Cellular Immunotherapy for Cancer offers readers a comprehensive review of current cellular and gene-based immunotherapies. Divided into eighteen cohesive chapters, this book provides an in-depth and detailed look into cellular-based immunotherapies including CAR-T, TCR-T, TIL, Viral CTLs, NK cells in addition to T/NK cell engagers, focusing on their historical perspectives, biology, development and manufacturing, toxicities and more.

Edited by two leading experts on gene and cellular immunotherapy, the book will feature chapters written by a diverse collection of recognized and up-and-coming experts and researchers in the field, providing oncologists, immunologists, researchers and clinical and basic science trainees with a bench to bedside view of the latest developments in the field." --publisher

ISBN

9783030878481

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Russo, Antonio

Maurea, Nicola

Farmakis, Dimitrios

Giordano, Antonio

Place of Publication

Cham, Switzerland

Publisher

Springer

Publication Date

2022

Series

Proquest Ebook Central

Current clinical pathology

Subjects

Cardiotoxicity - complications

Neoplasms - complications

Immunotherapy - adverse effects

ISBN

9783030977436

9783030977443

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer network computer. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Alternate Title

National Comprehensive Cancer Network guidelines for patients : immunotherapy side effects: CAR T-cell therapy

Corporate Author

National Comprehensive Cancer Network (NCCN)

Place of Publication

Plymouth Meeting, PA

Publisher

National Comprehensive Cancer Network

Publication Date

2022

Physical Description

32 p. : col. ill. ; 29 cm

Series

NCCN guidelines for patients

Subjects

Popular Work

Immunotherapy, Adoptive - adverse effects

Immunotherapy - adverse effects

ISBN

9781954190627

Language

English

Material Type

Book

Online

Audience

Patient or Public

Location

Internet

Abbotsford Cancer Info Ctr

Kelowna Cancer Info Ctr

Victoria Cancer Info Ctr

Vancouver Library

Call Number

QZ267 N277c 2022

Copies

Alternate Title

National Comprehensive Cancer Network guidelines for patients : immunotherapy side effects - immune checkpoint inhibitors

Corporate Author

National Comprehensive Cancer Network (NCCN)

Place of Publication

Plymouth Meeting, PA

Publisher

National Comprehensive Cancer Network

Publication Date

2022

Physical Description

58 p. : col. ill. ; 29 cm

Series

NCCN guidelines for patients

Subjects

Popular Work

Immunotherapy - adverse effects

ISBN

9781954190573

Language

English

Material Type

Book

Online

Audience

Patient or Public

Location

Internet

Abbotsford Cancer Info Ctr

Kelowna Cancer Info Ctr

Victoria Cancer Info Ctr

Vancouver Library

Call Number

QZ267 N277i 2022

Copies

Author

Hays, Priya

Edition

1st ed.

Place of Publication

Cham, Switzerland

Publisher

Springer International Publishing AG

Publication Date

c2022

Series

Proquest Ebook Central

Subjects

Hematologic Neoplasms

Neoplasms

Immunotherapy

Abstract

"This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer immunotherapies fall broadly into three categories: immune checkpoint inhibitors (ICIs), adoptive T cell therapies, and cancer vaccines which have distinct mechanisms of action. Immune checkpoint inhibitors rely upon disrupting tumor antigen recognition as self by the immune system through inhibition of checkpoint molecules. Adoptive T cell therapies involve the engineering of T cells ex vivo to target and destroy tumor cells.

The first part of this book will provide an overview of the discovery and mechanistic details of the technology. The second part will be devoted to elaborating on the clinical outcomes, successes and limitations for specific tumor subtypes, which includes both solid tumors and hematologic malignances for both pediatric and adult populations. As such, the book offers a valuable resource for oncologists, hematologists, and all those seeking an up-to-date overview of cancer immunotherapies." --publisher

ISBN

9783030963750

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Olsen, MiKaela

Edition

2nd

Place of Publication

Pittsburgh, PA

Publisher

Oncology Nursing Society

Publication Date

2024

Series

Proquest Ebook Central

Subjects

Chemotherapy

Drug Therapy

Immunotherapy

Neoplasms - nursing

Neoplasms - therapy

Neoplasms - drug therapy

Antineoplastic Agents - administration & dosage

Antineoplastic Agents - adverse effects

Nurses' Instruction

Practice Guideline

ISBN

9781635930559

9781635930566

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Vishvakarma, Naveen Kumar

Nagaraju, Ganji Purnachandra

Shukla, Dhananjay

Place of Publication

Cham, Switzerland

Publisher

Springer

Publication Date

2021

Series

Proquest Ebook Central

Subjects

Colorectal Neoplasms

ISBN

9783030646684

9783030646677

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer network computer. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Malviya, Rishabha

Singh, Arun Kumar

Yadav, Deepika

Edition

1st ed.

Place of Publication

Beverly, MA

Publisher

Scrivener Publishing

Publication Date

c2023

Series

Proquest Ebook Central

Subjects

Chemotherapy

Drug Resistance, Neoplasm

Abstract

"The book details the mechanisms underlying multi-drug cellular resistance and the targets of novel chemotherapeutic agents.

Cancer is a major killer all over the world. Even with all the progress made, chemotherapy is still the mainstay of modern cancer treatment. The progression of the cellular defeat of numerous independent anticancer drugs in terms of their chemical structure is a major barrier to successful chemotherapy. Multi-drug resistance (MDR) is a term for the fact that most cancer patients exhibit this phenomenon. According to the numbers, drug resistance carries the blame for 90% of cancer patient deaths. Refractory cancer and tumor recurrence are common outcomes of prolonged chemotherapy. Because of the prevalence of drug-resistance mutations, the difficulty of treating tumors increases and the therapeutic efficacy of drugs decreases.

Multi-Drug Resistance in Cancer: Mechanism and Treatment Strategies contains nine chapters that cover topics such as: studying the mechanics of resistance to drugs by autophagy; studies to delineate the role of efflux transporters; expression of drug transporters; resistance to targeted therapies in breast cancer; advances in metallodrug driven combination treatment for cancer; and use of natural agents for the overcoming of cancer drug resistance.

The book aims to provide the latest data on the mechanisms of cellular resistance to anticancer agents currently used in clinical treatment. It provides a better understanding of the mechanisms of MDR and targets of novel chemotherapy agents which should guide future research concerning new effective strategies in cancer treatment.

Audience

This book is written for pharmaceutical and biomedical scientists and researchers at both the bench and in the clinic who are interested in the mechanisms and strategies for overcoming cancer's multi-drug resistance." --publisher

ISBN

9781394209217

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Author

Dettmer, Phillipp

Place of Publication

New York, NY

Publisher

Random House

Publication Date

2021

Physical Description

xviii, 341 p. : ill. ; 25 cm

Subjects

Immune System

Immunology

Popular Work

ISBN

9780593241318

Language

English

Material Type

Book

Audience

Patient or Public

Location

Victoria Cancer Info Ctr

Call Number

QW504 D483 2021

Copies

Editor

Bajek, Anna

Tylkowski, Bartosz

Place of Publication

Berlin

Publisher

De Gruyter

Publication Date

2021

Physical Description

xv, 248 p. ill. (chiefly col.) ; 25 cm.

Series

De Gruyter STEM

Subjects

Neoplasms -- diagnosis

Neoplasms -- drug therapy

Translational Research, Biomedical

Antineoplastic Agents

ISBN

9783110662290

Material Type

Book

Audience

Professional

Location

Vancouver Library

Call Number

QZ241 M489b 2021

Copies

Editor

Charron, Neil

Place of Publication

New York

Publisher

Nova Science Publishers, Inc

Publication Date

2020

Series

Proquest Ebook Central

Cancer etiology, diagnosis and treatments

Subjects

Neoplasms - therapy

Genetic Therapy

Immunotherapy

Abstract

Summary:

"This compilation attempts to provide readers with brief and concise information on different types of cancer, their origins, and available treatment options. Protein kinase inhibitors, currently in clinical practice and under research for potential clinical usefulness, are also reviewed.Currently employed gene therapy strategies, obstacles, and challenges in cancer gene therapy are presented, focusing on the latest nanotechnological advancements in this field including gene transfer methods, vectors, and their current successful applications in cancer gene therapy.Lastly, sulfamethoxazole is examined for its history of combating several microbial infections by affecting folic acid biosynthesis inhibiting dihydropteroate synthetase." - Provided by publisher.

ISBN

9781536184501

9781536185874

Language

English

Material Type

Ebook

Audience

Patient or Public

Location

Internet

Website Notes

This resource was purchased with a donation from the Order of the Eastern Star.

Patients and the public of BC and the Yukon can access this title by emailing library@bccancer.bc.ca or calling 1.888.675.8001 x 7000 (toll-free) to obtain a username and password.

Editor

Lee, Daniel W.

Shah, Nirali N.

Place of Publication

Cambridge, MA

Publisher

Elsevier, Inc.

Publication Date

2020

Physical Description

xiv, 229 p. : ill. ; 24 cm.

Subjects

Neoplasms - therapy

Receptors, Chimeric Antigen - therapeutic use

Receptors, Antigen, T-Cell

Immunotherapy, Adoptive - methods

Cell- and Tissue-Based Therapy

Abstract

Contents:

Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients receiving CAR therapy -- Neurotoxicities after CAR-T cell immunotherapy -- Hematologic and non-CRS toxicities -- Response assessment and post-CAR-T cell therapy management -- Relapse management and role for consolidative hematopoietic stem cell transplantation following CAR-T cell therapy -- Promising chimeric antigen receptors for non-B cell hematological malignancies, pediatric solid tumors, and carcinomas -- CAR T cell therapy for CNS malignancies -- CAR 2.0: the next generation of synthetic receptor-based cellular therapy for cancer.

ISBN

9780323661812

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Abbotsford Library

Victoria Library

Call Number

QZ266 C538 2020

Copies